The aim of this systematic review was to identify, assess, and critically evaluate the quality of
evidence of nonsteroidal anti‐inflammatory drug (NSAID)‐induced adverse effects in dogs …

Objectives To discuss the clinical pharmacology of currently licensed veterinary NSAIDs and
to review gastrointestinal and renal adverse effects as well as drug-drug interactions that …

The practice of modern anesthesiology has been developed from intraoperative period into
perioperative period. Postoperative pain management is one of the most important …

Mavacoxib is a novel nonsteroidal anti‐inflammatory drug (NSAID), with a preferential action
on the cyclooxygenase (COX)‐2 isoform of COX and a long duration of action. It is classified …

Therapeutic products quite often are causes of poisoning in both small and large animals.
Drug poisonings in animals occur commonly due to off-label use of medicines, wrong …

Pelligand, L., King, JN, Toutain, PL, Elliott, J., Lees, P. Pharmacokinetic/pharmacodynamic
modelling of robenacoxib in a feline tissue cage model of inflammation. J. vet. Pharmacol …

Reasons for performing study Two firocoxib preparations for oral use are approved for use in
animals in many countries: a chewable canine tablet and an equine paste. In order to …

Gastroduodenal ulceration in small animals is a complex and important comorbidity that
occurs when the physiological homeostasis of the gastrointestinal tract is disrupted …

King, JN, Arnaud, JP, Goldenthal, EI, Gruet, P., Jung, M., Seewald, W., Lees, P. Robenacoxib
in the dog: target species safety in relation to extent and duration of inhibition of COX‐1 and …

Objective DA-9601, an extract of Artemisia asiatica containing eupatilin and jaceosidin as
active compounds, has been prescribed to treat gastritis in Asia. In recent times, sustained …